What Researchers Did
The researchers compared the effectiveness of a portable hyperbaric chamber with oxygen therapy for treating acute mountain sickness in 24 patients at high altitude.
What They Found
Both hyperbaric treatment and oxygen therapy effectively reduced symptoms of acute mountain sickness. Patients receiving hyperbaric treatment saw their oxygen saturation increase by 7% (from 84% to 91%), while those on oxygen therapy had a 14% increase (from 83% to 96%). Despite oxygen therapy leading to higher oxygen saturation, both treatments provided equally rapid relief of symptoms, which lasted for at least one hour after treatment.
What This Means for Canadian Patients
For Canadian patients experiencing acute mountain sickness, this study suggests that a portable hyperbaric chamber could be an effective option for immediate symptom relief, similar to traditional oxygen therapy. This could be particularly relevant for those in remote areas or during expeditions where access to oxygen might be limited, but a portable chamber is available.
Canadian Relevance
This study was not conducted in Canada, nor did it involve Canadian authors. Acute mountain sickness is not a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection identified.
Study Limitations
This study involved a small number of participants (24 patients) and was conducted over 30 years ago, which may limit the generalizability of its findings to current practices.